Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in acute ischemic stroke (phase 2, randomized, double-blind, placebo-controlled)
2010-020603-79Phase 2Completed
- Sponsor
- AB Science
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Masitinib with Placebo (2 arms). Primary endpoint: Modified Rankin Scale success at week 12. Started Oct 2012; status: completed.
02
Drugs
masitinib
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2010-020603-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020603-79.